Delveinsight

AUGUST 20, 2021

Invasive options mainly surgeries that involve the injection of therapeutic agents into the anal canal or surgical repair of anal canal are often associted with patient relctance and non-compliance. However, pharma companies have taken the lead to expand in the Fecal Incontinence therapy market.

Marketing 98

Marketing Pharma Companies Life Science Compliance 98

XTalks

MAY 6, 2022

They discussed current challenges and solutions that life science companies and clinical development organizations have with the management of clinical data. As such, she is at home with scaling operations as well as developing strategies that drive revenue growth.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

FEBRUARY 11, 2022

It’s our representation of tracking the deidentified, which is important from a privacy and compliance point of view,” Sun says. “It One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

MAY 27, 2022

The possibilities are endless, and in the context of trial participation and access to medicine technologies could assist: Reduced assessment times and hence increased patient compliance. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next?

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. He takes us through the challenges of a successful launch and explains what pre-commercial companies need to focus on to hit their goals. ” says Hale.

Production 52

Production Sales Life Science Marketing 52

pharmaphorum

OCTOBER 3, 2022

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. About the author.

Branding 116

Branding Doctors Doctor Compliance 116

Delveinsight

SEPTEMBER 8, 2021

Especially in the field of Pharmaceutical & Life Sciences, a company’s all-around product life-cycle stages, which consist of planning, designing, constructing, product testing, and commissioning processes are provided by a Pharma Consultant. Pharma Consultant. Pharma Consultancy Modus Operandi.

Marketing 52

Marketing Production Sales Life Science 52

pharmaphorum

MARCH 18, 2021

A way to ensure compliance is to make sure the voice is not recorded but analysed and the full text is purged in real-time, leaving only the summarised call notes. Pharma companies and sales reps need to adapt to their customer behaviours to stay relevant”. This can overcome any privacy concerns. But it doesn’t stop there.

Sales 52

Sales Pharma Companies Engineer Life Science 52

Drug Discovery World

APRIL 3, 2023

I quickly recognised the commercial value of aptamers as being able to address the gap in the market where antibodies fail to perform, and together we established the business to begin aptamer development. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

pharmaphorum

JUNE 10, 2022

Commercial leaders should leverage the internal capabilities and centres of excellence that pharma companies are increasingly building. Data science teams at some biopharma companies are helping research and development, and commercial groups take advantage of data insights to drive clinical outcomes.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

pharmaphorum

APRIL 19, 2021

In an interview with pharmaphorum’s news editor Richard Staines, he reflected on the last year and how it could prove to be pivotal for the country’s biotech and life sciences industry. . He was previously co-founder of chief executive of PowderMed, a vaccines development company bought by Pfizer in 2006.

Vaccination 98

Vaccination Vaccine Life Science Antibody 98

Drug Discovery World

AUGUST 10, 2023

In this article, Amplexor asks some of the company’s closest industry partners and BE THE EXPERT event speakers for their views on the biggest developments in the Life Sciences Regulatory sphere over the last 12 months – and explore some of the most prominent themes and priorities seen throughout 2023.

Production 98

Production Life Science Development Manufacturing 98